Cargando…
Stromal depletion by TALEN-edited universal hypoimmunogenic FAP-CAR T cells enables infiltration and anti-tumor cytotoxicity of tumor antigen-targeted CAR-T immunotherapy
Adoptive cell therapy based on chimeric antigen receptor (CAR)-engineered T-cells has proven to be lifesaving for many cancer patients. However, its therapeutic efficacy has so far been restricted to only a few malignancies, with solid tumors proving to be especially recalcitrant to efficient therap...
Autores principales: | Das, Shipra, Valton, Julien, Duchateau, Philippe, Poirot, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213512/ https://www.ncbi.nlm.nih.gov/pubmed/37251405 http://dx.doi.org/10.3389/fimmu.2023.1172681 |
Ejemplares similares
-
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
por: Jo, Sumin, et al.
Publicado: (2022) -
Straightforward Generation of Ultrapure Off-the-Shelf Allogeneic CAR-T Cells
por: Juillerat, Alexandre, et al.
Publicado: (2020) -
An oxygen sensitive self-decision making engineered CAR T-cell
por: Juillerat, Alexandre, et al.
Publicado: (2017) -
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy
por: Valton, Julien, et al.
Publicado: (2015) -
Optimized tuning of TALEN specificity using non-conventional RVDs
por: Juillerat, Alexandre, et al.
Publicado: (2015)